Skip to content
healthcare.dev

REZLIDHIA

NDC 71332-005, olutasidenib, capsule, from Rigel Pharmaceuticals, Inc..

Product NDC
71332-005
Status
Listed
Labeler
Rigel Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215814
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71332-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLUTASIDENIB150 mg/1
Package NDCNDC-11Package
71332-005-017133200050130 CAPSULE in 1 BOTTLE (71332-005-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4a0c7c8b-b95f-455d-9600-b7351e4397fe

Use it

Look up 71332-005 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71332-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71332-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.